Clinicn Investigator, Assc Prf Cancer Center, Mass General Research Institute

Associate Professor of Medicine Harvard Medical School

Assistant Physician Medicine-Hematology and Medical Oncology, Massachusetts General Hospital

MD Havard Medical School 2000

MPH Harvard School of Public Health 2007

anticoagulation; cancer associated thrombosis; classical hematology; coagulation disorders; deep vein thrombosis; direct oral anticoagulants; evidence-based medicine; pregnancy associated thrombosis; pulmonary embolism; quality improvement; stress physiological; venous thromboembolism; venous thrombosis; women's health care

Dr. Rachel Rosovsky is a hematologist and clinical investigator at the Massachusetts General Hospital (MGH) and Associate Professor at Harvard Medical School.  She is also the Director of Thrombosis Research in Division of Hematology at MGH and Co-Chair of MGH’s Thrombosis Committee.  

Dr. Rosovsky specializes in disorders of clotting and bleeding.  Her clinical practice is devoted to the risks, diagnosis and treatment of clotting conditions such as pulmonary embolism (PE), deep vein thrombosis (DVT), cancer associated thrombosis, and antiphospholipid syndrome. As a clinical investigator, Dr. Rosovsky serves as the principle investigator for several clinical trials and is able to offer new treatment options to patients with these conditions.  Dr. Rosovsky is also the creator/director of Pulmonary Embolism Response Team multidisciplinary follow up clinic as well as runs the outpatient low risk PE and DVT clinic and patients with clotting problems are encouraged to schedule an appointment with Dr. Rosovsky

Dr. Rosovsky earned her undergraduate degree from University of Pennsylvania, medical degree from Harvard Medical School and Master's in Public Health from Harvard School of Public Health. She completed residency at Brigham and Women's Hospital and fellowship in hematology and medical oncology at the Dana-Farber Cancer Institute-Massachusetts General Hospital combined program.  

Dr. Rosovsky is one of the founders and current President of The Pulmonary Embolism Response Team (PERT) Consortium^TM, an organization focused on improving the care of patients with PE worldwide.  She also serves as the co-chair for American Heart Association VTE Committee and is an Associate Editor for the American Journal of Hematology.  She is on Executive Committee for Venous thromboEmbolism Network US (VENUS), Committee on Quality for the American Society of Hematology (ASH), and Medical and Scientific Advisory Board for the Foundation for Women and Girls with Bleeding Disorders (FWGBD).  Dr. Rosovsky collaborates with researchers worldwide, has published over 130 peer reviewed articles in this space, and has presented at numerous national and international conferences.  Through her research and clinical work, Dr. Rosovsky has sought to improve care of patients with blood clots and advance the understanding and treatment of this medical condition for the past 20 years.